Skip to main content
Main navigation
Our Company
Who we are
Senior Leadership Team
Board of Directors
Scientific Advisory Committee
Our Solutions
AGROBODY Foundry™
Product pipeline
Evoca™
Investors
Press releases
Financial information
Stock Information
Shareholder information
Corporate governance
Events
Presentations
Fact sheets
IPO
Partnering
News & Events
Press releases
Events
Stay in touch
Message from our CEO
Careers
Open Positions
Vision & Values
What our employees say
Benefits and wellbeing
Contact
User account menu
Log in
Go back
Biotalys announces end of Stabilization Period and the partial exercise of the Over-allotment Option in respect of 712,942 Shares in connection with its Initial Public Offering
Social Menu
Twitter
LinkedIn
Email
Press releases
Biotalys Starts Field Trials for Second Biofungicide
May 2, 2024
Biotalys Appoints Laura J. Meyer to Board of Directors
April 30, 2024
Results of the Ordinary and Extraordinary Shareholders’ Meeting
April 23, 2024
Discover all press releases